Myasthenia Gravis: Diagnosis & Access Challenges – Dr. Morgan
- Project ASPIRE (eliminAte diSparities and Promote equIty in Rare diseasE) is focusing on improving the diagnostic journeys of patients with rare neuromuscular conditions, notably myasthenia gravis.
- The project's initial analysis,based on patient surveys and interviews from January to May 2023,aims to identify areas where changes can be made through patient education.
- Morgan emphasized the importance of fostering dialog among specialists.
Project ASPIRE tackles diagnostic delays in myasthenia gravis, a rare neuromuscular disease. dr. Morgan’s research highlights the urgent need for initiatives that boost both patient education and physician awareness, crucial steps to ensure early detection. Addressing disparities in internet access is also a priority, as telehealth’s limitations have underscored the digital divide’s impact on equitable healthcare for those wiht myasthenia gravis. The project’s findings will inform targeted programs while advocating for policies to remove systemic barriers. At News Directory 3, we understand the power of details in healthcare. Discover what’s next in Project ASPIRE’s quest to improve outcomes and reduce diagnostic delays for patients.
Project ASPIRE Aims to Reduce Myasthenia Gravis Diagnosis delays
Updated June 13, 2025
Project ASPIRE (eliminAte diSparities and Promote equIty in Rare diseasE) is focusing on improving the diagnostic journeys of patients with rare neuromuscular conditions, notably myasthenia gravis. Dr. Marla Black Morgan, a neurologist with Phoebe Neurology Associates, presented research at the 2025 American Academy of Neurology outlining the project’s next steps.
The project’s initial analysis,based on patient surveys and interviews from January to May 2023,aims to identify areas where changes can be made through patient education. One suggestion from patients involved a web-based program where individuals could input symptoms and receive a list of potential diagnoses, including generalized myasthenia gravis. While healthcare professionals expressed caution about self-diagnosis, they acknowledged the potential benefit of tools that prompt patients to seek medical advice for symptoms beyond typical aches and pains.
Educating physicians is another critical strategy. Dr. Morgan emphasized the importance of fostering dialog among specialists. for example,neurologists could discuss potential myasthenia gravis diagnoses with ophthalmologists when patients present with drooping eyelids.
Addressing access issues is also a priority. While technology and web-based education are promising,Dr. Morgan noted that a significant portion of her patient population lacks high-speed internet access. The reliance on telehealth during the COVID-19 pandemic highlighted this disparity, which remains unresolved.
Identifying differences in treatment and outcomes is crucial for minority patients. According to Morgan, recognizing these disparities can inform treatment choices and improve patient response to therapies. Understanding why certain patients experience delays in diagnosis or have poorer responses to treatment is a vital piece of the puzzle.
what’s next
Project ASPIRE plans to use its findings to develop targeted patient education and physician awareness programs, while also advocating for policies that address systemic barriers to healthcare access for minority patients with myasthenia gravis and other rare neuromuscular conditions.